DTE vs VRCA
DTE (DTE) versus Verrica Pharmaceuticals Inc (VRCA) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
DTE does not have a complete income-statement cache yet.
Latest reported VRCA revenue for 2024-12-31 was $7.6M. Net income was -$76.6M. Revenue was up 47.7% from 2023-12-31 to 2024-12-31. VRCA currently screens at market cap $79.7M.
DTE currently screens at market cap $0. VRCA currently screens at market cap $79.7M.
Not investment advice. Open the DTE and VRCA stock pages for the full models.
Not investment advice.